Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-17

FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for labetalol hydrochloride (Hospira) authorizing continued marketing of the generic product under an approved suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)